| Product NDC: | 0575-6200 |
| Proprietary Name: | Proglycem |
| Non Proprietary Name: | diazoxide |
| Active Ingredient(s): | 50 mg/mL & nbsp; diazoxide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0575-6200 |
| Labeler Name: | Teva Global Respiratory Research LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017453 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19760528 |
| Package NDC: | 0575-6200-30 |
| Package Description: | 1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) > 30 mL in 1 BOTTLE, DROPPER |
| NDC Code | 0575-6200-30 |
| Proprietary Name | Proglycem |
| Package Description | 1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) > 30 mL in 1 BOTTLE, DROPPER |
| Product NDC | 0575-6200 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | diazoxide |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 19760528 |
| Marketing Category Name | NDA |
| Labeler Name | Teva Global Respiratory Research LLC |
| Substance Name | DIAZOXIDE |
| Strength Number | 50 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |